[1]
|
Cates Jr., W. (1999) Estimates of the Incidence and Prevalence of Sexually Transmitted Diseases in the United States. American Social Health Association Panel. Sexually Transmitted Diseases, 26, S2-S7.
https://doi.org/10.1097/00007435-199904001-00002
|
[2]
|
zur Hausen, H. (1999) Papillomaviruses in Human Cancers. Proceedings of the Association of American Physicians, 111, 581-587. https://doi.org/10.1046/j.1525-1381.1999.99723.x
|
[3]
|
Burd, E.M. (2003) Human Papillomavirus and Cervical Cancer. Clinical Microbiology Reviews, 16, 1-17.
https://doi.org/10.1128/CMR.16.1.1-17.2003
|
[4]
|
高飞, 张姝玥, 王致萍, 夏宁邵. 人乳头瘤病毒疫苗的研究现状及前景[J]. 中国生物制品学杂志, 2022, 35(7): 769-779. https://doi.org/10.13200/j.cnki.cjb.003667
|
[5]
|
Jin, X.W., Cash, J. and Kennedy, A.W. (1999) Human Papillo-mavirus Typing and the Reduction of Cervical Cancer Risk. Cleveland Clinic Journal of Medicine, 66, 533-539. https://doi.org/10.3949/ccjm.66.9.533
|
[6]
|
Franco, E.L. (1995) Cancer Causes Revisited: Human Papillomavirus and Cervical Neoplasia. Journal of the National Cancer Institute, 87, 779-780. https://doi.org/10.1093/jnci/87.11.779
|
[7]
|
Walboomers, J.M., Jacobs, M.V., Manos, M.M., Bosch, F.X., Kum-mer, J.A., Shah, K.V., Snijders, P.J., Peto, J., Meijer, C.J. and Muñoz, N. (1999) Human Papillomavirus Is a Necessary Cause of Invasive Cervical Cancer Worldwide. The Journal of Pathology, 189, 12-19.
https://doi.org/10.1002/(SICI)1096-9896(199909)189:1%3C12::AID-PATH431%3E3.0.CO;2-F
|
[8]
|
Andersson, S., Rylander, E., Larsson, B., Strand, A., Silfversvärd, C. and Wilander, E. (2001) The Role of Human Papillomavirus in Cervical Adenocarcinoma Carcinogenesis. European Journal of Cancer, 37, 246-250.
https://doi.org/10.1016/S0959-8049(00)00376-2
|
[9]
|
Roden, R.B., Lowy, D.R. and Schiller, J.T. (1997) Papillo-mavirus Is Resistant to Desiccation. The Journal of Infectious Diseases, 176, 1076-1079. https://doi.org/10.1086/516515
|
[10]
|
Adam, E., Berkova, Z., Daxnerova, Z., Icenogle, J., Reeves, W.C. and Kauf-man, R.H. (2000) Papillomavirus Detection: Demographic and Behavioral Characteristics Influencing the Identification of Cervical Disease. American Journal of Obstetrics and Gynecology, 182, 257-264. https://doi.org/10.1016/S0002-9378(00)70208-0
|
[11]
|
Burk, R.D., Kelly, P., Feldman, J., Bromberg, J., Vermund, S.H., DeHovitz, J.A. and Landesman, S.H. (1996) Declining Prevalence of Cervicovaginal Human Papillomavirus Infec-tion with Age Is Independent of Other Risk Factors. Sexually Transmitted Diseases, 23, 333-341. https://doi.org/10.1097/00007435-199607000-00013
|
[12]
|
Calore, E.E., Pereira, S.M. and Cavaliere, M.J. (2001) Progression of Cervical Lesions in HIV-Seropositive Women: A Cytological Study. Diagnostic Cytopathology, 24, 117-119.
https://doi.org/10.1002/1097-0339(200102)24:2%3C117::AID-DC1021%3E3.0.CO;2-P
|
[13]
|
Cubie, H.A., Seagar, A.L., Beattie, G.J., Monaghan, S. and Williams, A.R. (2000) A Longitudinal Study of HPV Detection and Cervical Pa-thology in HIV Infected Women. Sexually Transmitted Diseases, 76, 257-261.
https://doi.org/10.1136/sti.76.4.257
|
[14]
|
Torrisi, A., Del Mistro, A., Onnis, G.L., Merlin, F., Bertorelle, R. and Minucci, D. (2000) Colposcopy, Cytology and HPV-DNA Testing in HIV-Positive and HIV-Negative Women. Euro-pean Journal of Gynaecological Oncology, 21, 168-172. https://doi.org/10.1097/00126334-199905010-00031
|
[15]
|
Brisson, J., Morin, C., Fortier, M., Roy, M., Bouchard, C., Leclerc, J., Christen, A., Guimont, C., Penault, F. and Meisels, A. (1994) Risk Factors for Cervical Intraepithelial Neoplasia: Differences between Low- and High-Grade Lesions. American Journal of Epidemiology, 140, 700-710. https://doi.org/10.1093/oxfordjournals.aje.a117318
|
[16]
|
Phillips, D.H. and Ni Shé, M. (1993) Smoking-Related DNA Adducts in Human Cervical Biopsies. IARC Scientific Publications, No. 124, 327-330.
|
[17]
|
Villa, L.L. (1997) Human Papillomaviruses and Cervical Cancer. Advances in Cancer Research, 71, 321-341.
https://doi.org/10.1016/S0065-230X(08)60102-5
|
[18]
|
Yang, X., Jin, G., Nakao, Y., Rahimtula, M., Pater, M.M. and Pater, A. (1996) Malignant Transformation of HPV 16-Immortalized Human Endocervical Cells by Cigarette Smoke Condensate and Characterization of Multistage Carcinogenesis. International Journal of Cancer, 65, 338-344.
https://doi.org/10.1002/(SICI)1097-0215(19960126)65:3%3C338::AID-IJC11%3E3.0.CO;2-6
|
[19]
|
zur Hausen, H. (1982) Human Genital Cancer: Synergism between Two Virus Infections or Synergism between a Virus Infection and Initiating Events? The Lancet, 2, 1370-1372. https://doi.org/10.1016/S0140-6736(82)91273-9
|
[20]
|
Chen, M., Popescu, N., Woodworth, C., Berneman, Z., Corbellino, M., Lusso, P., Ablashi, D.V. and DiPaolo, J.A. (1994) Human Herpesvirus 6 Infects Cervical Epithelial Cells and Transactivates Human Papillomavirus Gene Expression. Journal of Virology, 68, 1173-1178. https://doi.org/10.1128/jvi.68.2.1173-1178.1994
|
[21]
|
Razzaque, A., Williams, O., Wang, J. and Rhim, J.S. (1993) Neoplastic Transformation of Immortalized Human Epidermal Keratinocytes by Two HHV-6 DNA Clones. Virology, 195, 113-120. https://doi.org/10.1006/viro.1993.1351
|
[22]
|
Romano, N., Romano, F.M., Viviano, E., Vitale, F., Villafrate, M.R., Perna, A.M., Bonura, F. and Guttadauro, R. (1996) Rare Association of Human Herpesvirus 6 DNA with Human Papillomavirus DNA in Cervical Smears of Women with Normal and Abnormal Cy-tologies. Journal of Clinical Microbiology, 34, 1589-1591.
https://doi.org/10.1128/jcm.34.6.1589-1591.1996
|
[23]
|
Shen, C.Y., Ho, M.S., Chang, S.F., Yen, M.S., Ng, H.T., Huang, E.S. and Wu, C.W. (1993) High Rate of Concurrent Genital Infections with Human Cytomegalovirus and Human Papillomaviruses in Cervical Cancer Patients. The Journal of Infectious Diseases, 168, 449-452. https://doi.org/10.1093/infdis/168.2.449
|
[24]
|
Chan, P.K., Chan, M.Y., Li, W.W., Chan, D.P., Cheung, J.L. and Cheng, A.F. (2001) Association of Human Beta-Herpesviruses with the Development of Cervical Cancer: Bystanders or Cofactors. Journal of Clinical Pathology, 54, 48-53. https://doi.org/10.1136/jcp.54.1.48
|
[25]
|
Swan, D.C., Tucker, R.A., Tortolero-Luna, G., Mitchell, M.F., Wideroff, L., Unger, E.R., Nisenbaum, R.A., Reeves, W.C. and Icenogle, J.P. (1999) Human Papillomavirus (HPV) DNA Copy Number Is Dependent on Grade of Cervical Disease and HPV Type. Journal of Clinical Microbiology, 37, 1030-1034.
https://doi.org/10.1128/JCM.37.4.1030-1034.1999
|
[26]
|
Zerbini, M., Venturoli, S., Cricca, M., Gallinella, G., De Simone, P., Costa, S., Santini, D. and Musiani, M. (2001) Distribution and Viral Load of Type Specific HPVs in Dif-ferent Cervical Lesions as Detected by PCR-ELISA. Journal of Clinical Pathology, 54, 377-380. https://doi.org/10.1136/jcp.54.5.377
|
[27]
|
zur Hausen, H. (1996) Papillomavirus Infections—A Major Cause of Human Cancers. Biochimica et Biophysica Acta, 1288, F55-F78. https://doi.org/10.1016/0304-419X(96)00020-0
|
[28]
|
Giannoudis, A. and Herrington, C.S. (2001) Human Papil-lomavirus Variants and Squamous Neoplasia of the Cervix. The Journal of Pathology, 193, 295-302.
https://doi.org/10.1002/1096-9896(2000)9999:9999%3C::AID-PATH809%3E3.0.CO;2-C
|
[29]
|
Stöppler, M.C., Ching, K., Stöppler, H., Clancy, K., Schlegel, R. and Icenogle, J. (1996) Natural Variants of the Human Papillomavirus Type 16 E6 Protein Differ in Their Abilities to Alter Keratinocyte Differentiation and to Induce p53 Degradation. Journal of Virology, 70, 6987-6993. https://doi.org/10.1128/jvi.70.10.6987-6993.1996
|
[30]
|
Veress, G., Szarka, K., Dong, X.P., Gergely, L. and Pfister, H. (1999) Functional Significance of Sequence Variation in the E2 Gene and the Long Control Region of Human Papillomavirus Type 16. Journal of General Virology, 80, 1035-1043. https://doi.org/10.1099/0022-1317-80-4-1035
|
[31]
|
Dong, X.P., Stubenrauch, F., Beyer-Finkler, E. and Pfister, H. (1994) Prevalence of Deletions of YY1-Binding Sites in Episomal HPV 16 DNA from Cervical Cancers. International Journal of Cancer, 58, 803-808.
https://doi.org/10.1002/ijc.2910580609
|
[32]
|
Hildesheim, A., Schiffman, M., Bromley, C., Wacholder, S., Herrero, R., Rodriguez, A., Bratti, M.C., Sherman, M.E., Scarpidis, U., Lin, Q.Q., Terai, M., Bromley, R.L., Buetow, K., Apple, R.J. and Burk, R.D. (2001) Human Papillomavirus Type 16 Variants and Risk of Cervical Cancer. Journal of the Na-tional Cancer Institute, 93, 315-318.
https://doi.org/10.1093/jnci/93.4.315
|
[33]
|
Allen, M., Kalantari, M., Ylitalo, N., Pettersson, B., Hagmar, B., Scheibenpflug, L., Johansson, B., Petterson, U. and Gyllensten, U. (1996) HLA DQ-DR Haplotype and Susceptibility to Cervical Carcinoma: Indications of Increased Risk for Development of Cervical Carcinoma in Individuals Infected with HPV 18. Tissue Antigens, 48, 32-37.
https://doi.org/10.1111/j.1399-0039.1996.tb02602.x
|
[34]
|
Apple, R.J., Becker, T.M., Wheeler, C.M. and Erlich, H.A. (1995) Comparison of Human Leukocyte Antigen DR-DQ Disease Associations Found with Cervical Dysplasia and Invasive Cervical Carcinoma. Journal of the National Cancer Institute, 87, 427-436. https://doi.org/10.1093/jnci/87.6.427
|
[35]
|
Bontkes, H.J., van Duin, M., de Gruijl, T.D., Duggan-Keen, M.F., Walboomers, J.M., Stukart, M.J., Verheijen, R.H., Helmerhorst, T.J., Meijer, C.J., Scheper, R.J., Stevens, F.R., Dyer, P.A., Sinnott, P. and Stern, P.L. (1998) HPV 16 Infection and Progression of Cervical Intra-Epithelial Neoplasia: Analy-sis of HLA Polymorphism and HPV 16 E6 Sequence Variants. International Journal of Cancer, 78, 166-171.
https://doi.org/10.1002/(SICI)1097-0215(19981005)78:2%3C166::AID-IJC8%3E3.0.CO;2-X
|
[36]
|
王利琼, 杨雅嵋, 江毅敏, 袁芳桃, 张科荣. 宫颈癌患者HPV基因型分布及HPV52编码基因突变情况分析[J]. 中国病原生物学杂志, 2022, 17(7): 810-813. https://doi.org/10.13350/j.cjpb.220714
|
[37]
|
Magnusson, P.K., Lichtenstein, P. and Gyllensten, U.B. (2000) Heritability of Cervical Tumours. International Journal of Cancer, 88, 698-701. https://doi.org/10.1002/1097-0215(20001201)88:5%3C698::AID-IJC3%3E3.0.CO;2-J
|
[38]
|
Jacobs, M.V., Snijders, P.J., van den Brule, A.J., Helmerhorst, T.J., Meijer, C.J. and Walboomers, J.M. (1997) A General Primer GP5+/GP6(+)-Mediated PCR-Enzyme Immunoassay Method for Rapid Detection of 14 High-Risk and 6 Low-Risk Human Papillomavirus Genotypes in Cervical Scrapings. Journal of Clinical Microbiology, 35, 791-795.
https://doi.org/10.1128/jcm.35.3.791-795.1997
|
[39]
|
Kleter, B., van Doorn, L.J., Schrauwen, L., Molijn, A., Sastrowijoto, S., ter Schegget, J., Lindeman, J., ter Harmsel, B., Burger, M. and Quint, W. (1999) Development and Clinical Evaluation of a Highly Sensitive PCR-Reverse Hybridization Line Probe Assay for Detection and Identification of Anogenital Human Papillomavirus. Journal of Clinical Microbiology, 37, 2508-2517. https://doi.org/10.1128/JCM.37.8.2508-2517.1999
|
[40]
|
Quint, W.G., Scholte, G., van Doorn, L.J., Kleter, B., Smits, P.H. and Lindeman, J. (2001) Comparative Analysis of Human Papillomavirus Infections in Cervical Scrapes and Biopsy Specimens by General SPF(10) PCR and HPV Genotyping. The Journal of Pathology, 194, 51-58. https://doi.org/10.1002/path.855
|
[41]
|
Coker, A.L., Russell, R.B., Bond, S.M., Pirisi, L., Liu, Y., Mane, M., Ko-korina, N., Gerasimova, T. and Hermonat, P.L. (2001) Adeno-Associated Virus Is Associated with a Lower Risk of High-Grade Cervical Neoplasia. Experimental and Molecular Pathology, 70, 83-89. https://doi.org/10.1006/exmp.2000.2347
|
[42]
|
Su, P.F., Chiang, S.Y., Wu, C.W. and Wu, F.Y. (2000) Adeno-Associated Virus Major Rep78 Protein Disrupts Binding of TATA-Binding Protein to the p97 Promoter of Hu-man Papillomavirus Type 16. Journal of Virology, 74, 2459-2465.
https://doi.org/10.1128/JVI.74.5.2459-2465.2000
|
[43]
|
Obalek, S., Jablonska, S. and Orth, G. (1985) HPV-Associated Intraepithelial Neoplasia of External Genitalia. Clinics in Dermatology, 3, 104-113. https://doi.org/10.1016/0738-081X(85)90054-9
|
[44]
|
De Villez, R.L. and Stevens, C.S. (1980) Bowenoid Papules of the Genitalia. A Case Progressing to Bowen’s Disease. Journal of the American Academy of Dermatology, 3, 149-152. https://doi.org/10.1016/S0190-9622(80)80252-0
|
[45]
|
Harro, C.D., Pang, Y.Y., Roden, R.B., Hildesheim, A., Wang, Z., Reynolds, M.J., Mast, T.C., Robinson, R., Murphy, B.R., Karron, R.A., Dillner, J., Schiller, J.T. and Lowy, D.R. (2001) Safety and Immunogenicity Trial in Adult Volunteers of a Human Papillomavirus 16 L1 Virus-Like Particle Vaccine. Journal of the National Cancer Institute, 93, 284-292. https://doi.org/10.1093/jnci/93.4.284
|
[46]
|
Centers for Disease Control and Prevention (CDC) (2000) Incidence of Pap Test Abnormalities within 3 Years of a Normal Pap Test—United States, 1991-1998. Morbidity and Mortality Weekly Report, 49, 1001-1003.
|